The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 8,573,950 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | |||
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 3,885,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 407,550 | 6,500 | SH | SOLE | 6,500 | 0 | 0 | |||
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | 161,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 2,763,871 | 185,122 | SH | SOLE | 185,122 | 0 | 0 | |||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 262,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 244,140 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | |||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 2,538,000 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 212,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| EDESA BIOTECH INC | COM NEW | 27966L306 | 4,327,825 | 827,500 | SH | SOLE | 827,500 | 0 | 0 | |||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 4,712,800 | 1,720,000 | SH | SOLE | 1,720,000 | 0 | 0 | |||
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 2,548,480 | 352,000 | SH | SOLE | 352,000 | 0 | 0 | |||
| EVOMMUNE INC | COM SHS | 30054Y107 | 10,259,402 | 446,255 | SH | OTR | 0 | 446,255 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 22,995 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
| HERON THERAPEUTICS INC | COM | 427746102 | 7,003,507 | 8,753,290 | SH | SOLE | 8,753,290 | 0 | 0 | |||
| IMMIX BIOPHARMA INC | COM | 45258H106 | 6,741,400 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | |||
| IMMUNOME INC | COM | 45257U108 | 218,700 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| INSPIREMD INC | COM | 45779A846 | 3,422,433 | 2,099,652 | SH | SOLE | 2,099,652 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 2,123,091 | 2,423,067 | SH | SOLE | 2,423,067 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 214,956 | 245,328 | SH | OTR | 0 | 245,328 | 0 | |||
| KALARIS THERAPEUTICS INC | COM | 482929106 | 103,860 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 83,550 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | 48669G303 | 1,006,744 | 135,315 | SH | SOLE | 135,315 | 0 | 0 | |||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 148,500 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | |||
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | 2,046,120 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | |||
| MACROGENICS INC | COM | 556099109 | 86,700 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | 10,020,515 | 492,893 | SH | OTR | 0 | 492,893 | 0 | |||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 297,990 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | |||
| NASUS PHARMA LTD | ORD SHS | M7071P109 | 797,846 | 359,390 | SH | SOLE | 359,390 | 0 | 0 | |||
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 156,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 248,000 | 16,000 | SH | SOLE | 16,000 | 0 | 0 | |||
| OVID THERAPEUTICS INC | COM | 690469101 | 355,200 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 90,520 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 32,470,630 | 100,781 | SH | SOLE | 100,781 | 0 | 0 | |||
| PRECISION BIOSCIENCES INC | COM NEW | 74019P207 | 220,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
| PROFOUND MED CORP | COM NEW | 74319B502 | 1,851,401 | 285,710 | SH | SOLE | 285,710 | 0 | 0 | |||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 72,900 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 389,980 | 3,700 | SH | SOLE | 3,700 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 14,768,537 | 2,834,652 | SH | SOLE | 2,834,652 | 0 | 0 | |||
| QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L409 | 560,003 | 84,849 | SH | SOLE | 84,849 | 0 | 0 | |||
| REPLIMUNE GROUP INC | COM | 76029N106 | 153,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 2,287,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 1,054,822 | 294,643 | SH | SOLE | 294,643 | 0 | 0 | |||
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | 12,757,906 | 512,160 | SH | SOLE | 512,160 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 233,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | 9,327,495 | 583,333 | SH | SOLE | 583,333 | 0 | 0 | |||
| VERRICA PHARMACEUTICALS INC | COM SHS | 92511W207 | 2,494,547 | 471,559 | SH | SOLE | 471,559 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 1,782,366 | 91,123 | SH | SOLE | 91,123 | 0 | 0 | |||
| XENCOR INC | COM | 98401F105 | 3,015,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T209 | 120,137 | 14,285 | SH | SOLE | 14,285 | 0 | 0 | |||